Coronary artery disease risk prediction by combined stratification of low-density lipoprotein-cholesterol and high-density lipoprotein-cholesterol levels across different glucose statuses

被引:0
|
作者
Yachida, Junko [1 ,2 ]
Fujihara, Kazuya [1 ]
Yamada, Mayuko Harada [1 ]
Kobayashi, Ayako [1 ,2 ]
Khin, Lay Mon [1 ]
Takizawa, Hiroki [1 ]
Yamamoto, Masahiko [1 ]
Kitazawa, Masaru [1 ]
Matsubayashi, Yasuhiro [1 ]
Yamada, Takaho [1 ]
Kodama, Satoru [1 ]
Sone, Hirohito [1 ]
机构
[1] Niigata Univ, Dept Hematol Endocrinol & Metab, Fac Med, Niigata, Japan
[2] Niigata Coll Nursing, Joetsu, Japan
基金
日本学术振兴会;
关键词
cardiovascular disease; coronary artery disease; glucose abnormalities; high-density lipoprotein cholesterol; low-density lipoprotein cholesterol; STATIN-TREATED PATIENTS; APOLIPOPROTEIN-A-I; HEART-DISEASE; CARDIOVASCULAR-DISEASE; HDL CHOLESTEROL; INSULIN-RESISTANCE; TOLERANCE STATUS; LDL CHOLESTEROL; MORTALITY; JAPAN;
D O I
10.1111/dom.15956
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: To investigate the association between low-density lipoprotein-cholesterol (LDL-C) levels and coronary artery disease (CAD) incidence based on combining high-density lipoprotein-cholesterol (HDL-C) levels and glucose status. Materials and Methods: In this retrospective cohort study, we used data from a nationwide claims database (1,524,289 individuals without a history of CAD or familial hypercholesterolaemia; 2008-2019). Cox proportional hazards modelling identified the risk of incident CAD by a novel combination of four HDL-C levels, seven LDL-C levels and glucose status. Results: During the follow-up period (mean: 5.5 years), 8301 (0.99/1000 person-years) events occurred. The risk of CAD increased from lower LDL-C levels accompanied by lower HDL-C levels regardless of the glucose status. Using the most favourable levels of HDL-C and LDL-C (i.e. 60-99 mg/dL and <80 mg/dL, respectively) as references, the hazard ratios (95% confidence interval) for the group with HDL-C levels <40 mg/dL and LDL-C levels <80 mg/dL were 2.74 (1.47-5.11), 2.52 (1.30-4.91) and 2.85 (1.68-4.84) for normoglycaemia, borderline glycaemia and diabetes, respectively. Comparison of the most favourable levels of HDL-C and LDL-C with their least favourable levels (i.e. <40 mg/dL and 180-199 mg/dL, respectively) revealed that the risk of new-onset CAD exhibited a 19-, nine- and seven-fold increase in individuals with normoglycaemia, borderline glycaemia and diabetes, respectively. Conclusions: To prevent CAD, LDL-C levels should be strictly controlled in patients with low HDL-C levels regardless of glucose tolerance. Individualized treatment, which involves setting target LDL-C levels based on glucose tolerance and HDL-C values, is required.
引用
收藏
页码:5845 / 5856
页数:12
相关论文
共 50 条
  • [41] Lower High-Density Lipoprotein Cholesterol is a Significant and Independent Risk for Coronary Artery Disease in Japanese Men
    Satoh, Hiroki
    Tomita, Kazuo
    Fujii, Satoshi
    Kishi, Reiko
    Tsutsui, Hiroyuki
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2009, 16 (06) : 792 - 798
  • [42] Dataset dependency of low-density lipoprotein-cholesterol estimation by machine learning
    Hidekazu, Ishida
    Nagasawa, Hiroki
    Yamamoto, Yasuko
    Doi, Hiroki
    Saito, Midori
    Ishihara, Yuya
    Fujita, Takashi
    Ishida, Mariko
    Kato, Yohei
    Kikuchi, Ryosuke
    Matsunami, Hidetoshi
    Takemura, Masao
    Ito, Hiroyasu
    Saito, Kuniaki
    ANNALS OF CLINICAL BIOCHEMISTRY, 2023, 60 (06) : 396 - 405
  • [43] Discordance of Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol with Severity of Coronary Artery Disease
    Castro, Iran
    Fontana Filho, Hugo
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2020, 114 (03) : 476 - 476
  • [44] Drugs Targeting High-Density Lipoprotein Cholesterol for Coronary Artery Disease Management
    Katz, Pamela M.
    Leiter, Lawrence A.
    CANADIAN JOURNAL OF CARDIOLOGY, 2012, 28 (06) : 667 - 677
  • [45] Utility of neutrophil-to-high-density lipoprotein-cholesterol ratio in patients with coronary artery disease: a narrative review
    Lamichhane, Pratik
    Agrawal, Anushka
    Abouainain, Yasmeen
    Abousahle, Salma
    Regmi, Prakash Raj
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2023, 51 (04)
  • [46] DECREASED HIGH-DENSITY LIPOPROTEIN-CHOLESTEROL LEVELS IN MALE PATIENTS WITH TRANSIENT ISCHEMIC ATTACKS
    SIRTORI, CR
    GIANFRANCESCHI, G
    GRITTI, I
    NAPPI, G
    BRAMBILLA, G
    PAOLETTI, P
    ATHEROSCLEROSIS, 1979, 32 (02) : 205 - 211
  • [47] Contribution of High Plasma Triglycerides and Low High-Density Lipoprotein Cholesterol to Residual Risk of Coronary Heart Disease After Establishment of Low-Density Lipoprotein Cholesterol Control
    Carey, Vincent J.
    Bishop, Louise
    Laranjo, Nancy
    Harshfield, Benjamin J.
    Kwiat, Carolyn
    Sacks, Frank M.
    AMERICAN JOURNAL OF CARDIOLOGY, 2010, 106 (06) : 757 - 763
  • [48] Serum levels of remnant lipoprotein cholesterol and oxidized low-density lipoprotein in patients with coronary artery disease
    Hiki, Makoto
    Shimada, Kazunori
    Ohmura, Hirotoshi
    Kiyanagi, Takashi
    Kume, Atsumi
    Sumiyoshi, Katsuhiko
    Fukao, Kosuke
    Inoue, Nao
    Mokuno, Hiroshi
    Miyazaki, Tetsuro
    Daida, Hiroyuki
    JOURNAL OF CARDIOLOGY, 2009, 53 (01) : 108 - 116
  • [49] Associations of preoperative serum high-density lipoprotein cholesterol and low-density lipoprotein cholesterol levels with the prognosis of ovarian cancer
    Qingqing Lin
    Wenchao Liu
    Song Xu
    Liping Sun
    Archives of Gynecology and Obstetrics, 2022, 305 : 683 - 691
  • [50] Associations of preoperative serum high-density lipoprotein cholesterol and low-density lipoprotein cholesterol levels with the prognosis of ovarian cancer
    Lin, Qingqing
    Liu, Wenchao
    Xu, Song
    Sun, Liping
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2022, 305 (03) : 683 - 691